News

In a groundbreaking initiative poised to influence the future of gastric cancer treatment, an international team of researchers has launched a large-scale, multicenter randomized controlled trial investigating the impact of perioperative probiotic supplementation on patients undergoing minimally invasive radical gastrectomy following neoadjuvant chemotherapy (NACT). This

Colorectal cancer (CRC) ranks among the most prevalent and lethal malignancies worldwide, with its complex pathogenesis involving a convergence of genetic, epigenetic, immunological, and environmental factors. As populations age globally, the incidence of CRC continues to rise, underscoring the urgent need to deepen our understanding

In a groundbreaking new study, researchers have shed light on the crucial role of myocyte enhancer factor 2 (MEF2) family members—specifically MEF2A, MEF2C, and MEF2D—in the pathogenesis and prognosis of pancreatic adenocarcinoma (PAAD). Pancreatic cancer remains one of the deadliest malignancies worldwide due to its

Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) are unveiling groundbreaking advancements in cancer research at the prestigious American Association for Cancer Research (AACR) Annual Meeting in Chicago from

BETHESDA, MD – In a groundbreaking 20-year study conducted by the Kaiser Permanente Division of Research in Northern California, researchers have demonstrated that equitable, flexible colorectal cancer (CRC) screening strategies can decisively reduce both the incidence and mortality of this common malignancy, effectively eliminating longstanding

BETHESDA, MD. (April 25, 2025) — A groundbreaking study leveraging next-generation DNA sequencing has uncovered a critical set of genetic mutations that are intricately linked to aggressive and lethal forms of stomach cancer. Conducted by an international team of researchers and spearheaded by Dr. Ulysses

In a groundbreaking advancement for metastatic colorectal cancer treatment, researchers from City of Hope have revealed promising results from a Phase 3 clinical trial examining a novel combination therapy targeting the elusive KRAS G12C mutation. This mutation, found in a small but significant subset of

Intravenous Magnesium Emerges as a Protective Agent Against Cisplatin-Induced Kidney Injury: New Multicenter Study Sheds Light on a Promising Intervention Cisplatin remains one of the most potent chemotherapeutic agents available, widely employed in treating an array of malignancies, including lung, ovarian, bladder, and head and

Indiana University School of Medicine researchers have unveiled a groundbreaking imaging technique that promises to revolutionize the study of bone marrow in preclinical models. This advanced methodological breakthrough overcomes long-standing obstacles in visualizing this complex and crucial tissue, providing unprecedented insight into its cellular architecture

A groundbreaking study published in BMC Cancer unveils the intricate relationship between lactate metabolism and immune dynamics in head and neck squamous cell carcinoma (HNSCC), offering new hope for improved prognostic tools and targeted therapies. By harnessing integrated multi-omics approaches, researchers have identified specific gene